Staar Surgical Co (Staar Surgical Co) Forward Dividend Yield % : 0.00% (As of Jun. 07, 2024)

View and export this data going back to 1983. Start your Free Trial

What is Staar Surgical Co Forward Dividend Yield %?

As of today (2024-06-07), the Forward Annual Dividend Yield of Staar Surgical Co is 0.00%.

As of today (2024-06-07), the Trailing Annual Dividend Yield of Staar Surgical Co is 0.00%.

STAA's Forward Dividend Yield % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.965
* Ranked among companies with meaningful Forward Dividend Yield % only.

Staar Surgical Co's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Staar Surgical Co's Forward Dividend Yield %

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Staar Surgical Co's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Forward Dividend Yield % falls into.

Staar Surgical Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Staar Surgical Co (NAS:STAA) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Staar Surgical Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Staar Surgical Co (Staar Surgical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (NAS:STAA) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

SR3:Germany SR3:Germany

Address

25651 Atlantic Ocean Drive, Lake Forest, CA, USA, 92630

Website

https://www.staar.com

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.

Executives

Broadwood Partners Lp	10 percent owner	BROADWOOD CAPITAL INC., 142 WEST 57TH STREET, 11TH FLOOR, NEW YORK NY 10019
Elizabeth Yeu Lin	director	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
Aimee S Weisner	director	ONE EDWARDS WAY, IRVINE CA 92614
Warren Foust	officer: Chief Operating Officer	17 MAGNOLIA DRIVE, LADERA RANCH CA 92694
Magda Michna	officer: Chief Clinical, Regulatory,	C/O PRESBIA, 8845 IRVINE CENTER DRIVE, SUITE 100, IRVINE CA 92618
Keith Holliday	officer: V.P., Research & Development	1911 WALKER AVENUE, MONROVIA CA 91016
Robert Studholme	officer: Senior VP, Operations	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
James E Francese	officer: VP, Global Marketing	1911 WALKER AVE, MONROVIA CA 91016
Caren L Mason	director	2523 PARK RIDGE DRIVE, ESCONDIDO CA 92025
Samuel J Gesten	officer: VP, General Counsel	1911 WALKER AVENUE, MONROVIA CA 91016
Patrick F. Williams	officer: Chief Financial Officer	C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Hans-martin Blickensdoerfer	officer: VP, International Marketing	1911 WALKER AVENUE, MONROVIA CA 91016
Lou Silverman	director
Graydon C. Hansen	officer: Sr. VP, Global Operations	25651 ATLANTIC OCEAN DRIVE, LAKE FORST CA 92630
Jon K. Hayashida	officer: VP, Global Clinical, Medical	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630